1. General introduction of emergence and reemergence pathogens: emerging and reemerging viral pathogens 2. human re-emerging arboviral diseases of the late twenty-first century: from ecological-epidemiology to control strategies3. Viral emerging pathogen evolution4. Human viruses: emergence and evolution 5. The arenaviridae 6. Ecoepidemiology of alphaviruses and flaviviruses 7. Coronaviridae: 100,000 years of emergence and re-emergence8. The Middle East Respiratory Syndrome Coronavirus (MERS-CoV): An emerging virus of global threat 9. Hepatitis c virus and human herpesvirus 8: immunological response, modification of cell metabolism, and association with type 2 diabetes 10. Human immunodeficiency virus: a brief review 11. Ebola and marburg virus: a brief review 12. Undifferentiated tropical viral fevers in latin america 13. Chikungunya virus: a brief review of the thematic 14. Cytomegalovirus: an oncomodulator and therapeutic target in glioma management 15. Orthobunyavirus family of emerging viruses 16. Dengue virus 17. Oncoviruses: viruses' role in common human tumors 18. Oncogenic viruses 19. Noroviruses, sapoviruses and aichi viruses' emergence in wastewater associated with viral pandemic gastroenteritis 20. Rotaviruses, astroviruses and adenoviruses emergence and circulation in wastewater causing acute viral gastroenteritis 21. Prion diseases: conformational changes of a protein create an unconventional infectious agent 22. Vitamin D involvement in the viral etiology in emergent and reemergent in the chronic diseases 23. Viral etiology involved in the emergence of breast cancer 24. Emergence of oncogenic high-risk human papillomavirus (hpv) types and cervical cancer 25. Status of helicobacter pylori coinfection with epstein-barr virus in gastric cancer 26. 90 years of dna methylation 27. Emerging and re-emerging viral zoonotic diseases concepts, factors of emergence and re-emergency globalization of health threats 28. Capripoxvirus diseases: current updates and developed strategies for control 29. koi herpesvirus disease 29. viral nervous necrosis (vnn) disease 30. Viral hemorrhagic septicemia (vhs) disease 31. White spot syndrome virus (wssv) 32. Avian coronavirus: case of infectious bronchitis virus pathogenesis, diagnostic approaches and phylogenetic relationship among emerging strains in middle east and north africa (mena) regions 33. Role of genetic and molecular dynamics in the emergence, re-emergence and interspecies transmission of equine influenza viruses 34. Emerging and re-emerging fowl aviadenovirus infections 35. Avian retroviruses: case of viral arthritis disease overview of viral arthritis in poultry 36. Emergent mosquito-borne flaviviruses and animal diseases 37. Epidemiology and ecology of emerging viruses in two freshwater lakes of the northern hemisphere 38. Enteric adenoviruses: emerging of a public health threat 39. Waterborne transmission of enteric viruses and their impact on public health 40. Pacific oyster, crassostrea gigas mortality associated with the herpes virus: etiology and environmental emerging factors 41. Acute viral hepatitis a: a global health concern 42. Emergence of norovirus strains in worldwide distribution and environmental spreading 43. The waterborne and foodborne viral diseases related to re-emerging of poliovirusnnaji 44. Worldwide emerging and re-emerging rotavirus genotypes: genetic variability and inter-species transmission in health and environment 45. Emerging plant viruses 46. Risk assessment and biosecurity considerations in control of emergent plant viruses
Dr. Moulay Mustapha Ennaji, Professor in Virology and Oncology at the University of Casablanca and Director of the Quality and Medical Biotechnologies Team at Laboratory of Virology Microbiology, Quality, Biotechnologies/Eco-Toxicology and Biodiversity, Faculty of Sciences and Techniques, Hassan II University Mohammedia of Casablanca, Morocco
Prof. Dr. Moulay Mustapha Ennaji is a Moroccan and Canadian citizen and native of Marrakesh (Morocco). He is a scientist specializing in the fields of virology, hygiene, and microbiology and currently a Professor in Virology and Oncology at the University of Casablanca, and Since 2010, he has been the Director of the Quality and Medical Biotechnologies Team at the Laboratory of Virology Microbiology, Quality, Biotechnologies. He leads the Virology Oncology and Medical Biotechnology Team is and Deputy Director of the Research Centre of Natural Resources and Food (rensa) of UH2C. He has also been responsible for the master programs in biotechnology and biomedical technologies (2003), DESA of Microbiology and Bioengineering (2005-2010), Masters of Science and Technology in Microbiology, Applied Virology and Bio-industry Engineering, and MST of Livings in Immuno-Virology and Applied Microbiology (2010 to 2015). He received a MSc in 1986 and a PhD in virology in 1993 from Armand Frappier Institute, University of Quebec (Canada). Between 1991 and 1993 he completed a post doctorate at the Canadian Red Cross. From 1993 to 1995, he was a research associate (RA) and from 1995 to 1996 and a research officer (RO) at the National Council of Research of Canada (CNRC). He was also a visiting researcher at the University of California, Irvine in the United States and a lecturer at the Histochemistry Institutes of Paris (France). He was a guest researcher of the Franklin AU:1 Foundation in USA NIH Bethesda. He has published 61 journals articles and is an editorial board member of the journal, Infectious Agents and Cancer. As a scientist concerned with research development, he had been given numerous lectures in virology, cancerology, hygiene, and microbiology since 1986 at many Moroccan, Canadian, and American universities. Throughout his career, Dr. Ennaji has been rewarded 24 awards. He has organized numerous national and international meetings in the fields of virology, microbiology, and hygiene. At present, he is the vice president of the three Moroccan societies of Biosafety, Cancer, and Microbiology.